23andMe FOUNDER AND FORMER CEO ANNE WOJCICKI has successfully retained control over her company by selling it to her nonprofit medical research firm TTAM Research Institute for $305 million. This followed bidding between TTAM Research Institute and Regeneron Pharmaceuticals, which previously announced it had entered into a purchasing agreement to acquire most of the assets […]
Regeneron Loses 23andMe Bid to TTAM Research Institute
However, 26 states have filed a joint lawsuit to block the sale, citing data privacy concerns
- By Jillia Schlingman
- > From the Volume XXXII, No. 9 - June 23, 2025 Issue
- Tags: Anne Wojcicki, Biobank, City University of New York, Committee on Oversight and Government Reform, customer privacy ombudsman, Dan Rayfield JD, Dave Sunday JD, DNA samples, genetic data, genetic testing, House of Representatives, ivd/lab informatics, Joe Salsavage, Ken Paxton, Neil Richards JD, Personal Genome Service, PGS, privacy laws, property rights, Regeneron Pharmaceuticals, Rep. James Comer, Rep. Stephen Lynch, Research Services, The Washington Post, Total Health, TTAM Research Institute, US Bankruptcy Court for the Eastern District of Missouri, Vital Law, William Organek JD
